Sally Wagner Partin
Advertisement
Sally Wagner Partin is a partner at Sidley Austin LLP across life sciences M&A and FDA regulatory practice.
Articles by Sally Wagner Partin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
2
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
3
Pharmaceutical Executive Daily: FDA Approves Simtriyo
4
Why Gross-to-Net Internal Controls Should Be a Launch Priority for Specialty Pharma Companies
5